XML 44 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of Disaggregation of Revenue

Disaggregation of Revenue. In the following tables, revenues reported for the year ended December 31, 2021, under Topic 606, is disaggregated by type of revenue.

 

Type of Revenue   
Licensing  $11,000,000 
Sales-based royalties   54,994 
Minimum guaranteed royalties   4,050,000 
Materials   1,035,844 
Revenue $16,140,838 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

 

   Year Ended 
   2021   2020 
         
Research and development  $280,186   $583,212 
General and administrative   323,760    789,970 
           
   $603,946   $1,373,182 
Schedule of Key Assumption of Fair Value of Stock Options Granted

For options granted in 2021 and 2020, the Company calculated the fair value of each option grant on the respective dates of grant using the following weighted average assumptions:

 

   2021   2020 
Expected term   5.83 years    5.83 years 
Risk-free interest rate   1.04%   0.93%
Expected dividend yield        
Expected volatility   102.18%   100.32%
Schedule of Fair Value, Assets Measured on Recurring Basis

 

   December 31,   Fair value measurements at reporting date using 
   2021   Level 1 inputs   Level 2 inputs   Level 3 inputs 
                 
Assets:                    
Cash equivalents - money market funds  $2,089,751   $2,089,751   $-   $- 
Government treasury bills   5,515,920    5,515,920    -     -  
Commercial paper   15,385,634    -    15,385,634    - 
Corporate bonds and notes   22,787,651    -     22,787,651    -  
   $45,778,956   $7,605,671   $38,173,285   $- 
                     
Liabilities:                    
Warrant liability  $795,796    -    -    795,796 
   $46,574,752   $7,605,671   $38,173,285   $795,796 

 

    December 31,    Fair value measurements at reporting date using
    

2020

    Level 1 inputs    Level 2 inputs    Level 3 inputs 
                     
Assets:                    
Cash equivalents - money market funds  $18,399,585   $18,399,585   $-   $- 
Commercial paper   449,992    -    449,992    - 
                     
   $18,849,577   $18,399,585   $449,992   $- 
                     
Liabilities:                    
Warrant liability  $1,170,051    -    -    1,170,051 
   $20,019,628   $18,399,585   $449,992   $1,170,051 
Schedule of Computation of Basic and Diluted Earnings (loss) Per Share of Common Stock

The following table sets forth the computation of basic and diluted earnings (loss) per share of common stock for the years ended December 31, 2021 and 2020.

 

   Year Ended December 31, 
   2021   2020 
Basic loss per share attributable to common stock:          
Numerator          
Net loss  $(634,399)  $(20,964,819)
           
Denominator          
Weighted avg. common shares outstanding   86,934,618    55,688,085 
           
Basic loss per share attributable to common stock  $(0.01)  $(0.38)
           
Diluted loss per share attributable to common stock:          
Numerator          
Net loss  $(634,399)  $(20,964,819)
Denominator          
Weighted avg. common shares outstanding   86,934,618    55,688,085 
           
Diluted loss per share attributable to common stock  $(0.01)  $(0.38)
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The computation of diluted earnings per share for the years ended December 31, 2021 and 2020 does not include the following stock options or warrants to purchase shares in the computation of diluted earnings per share because these instruments were antidilutive:

 

   December 31, 
   2021   2020 
Stock options   4,551,205    3,564,458 
Warrants   1,934,366    1,944,366